Qualifyze, a Frankfurt, Germany-based compliance company, raised a $12 million funding round to accelerate growth.
Existing investors HV Capital and Rheingau Founders and new investors HarbourVest Partners and H14 participated in the round.
The company provides compliance solutions to the pharmaceutical industry, which allows them to check the compliance of supply chains. It offers a digital platform that can manage audits end-to-end, capturing audit data at scale.
“The speed of our growth and our continued success is proof of the value we are generating for our clients,” says Dr. David Schneider, CEO and founder of Qualifyze. “We are not just transforming how supplier audits are being performed. Qualifyze is creating a new category of compliance data, which will allow our clients to make more informed decisions to increase drug safety for their patients and to better allocate investments into supply chain compliance, even beyond GxP. This funding will help us accelerate our mission to transform supply chain compliance in healthcare in a sustainable, data-driven manner.”
Company: Qualifyze GmbH
Raised: $12.0M
Round: Unknown
Funding Month: August 2023
Lead Investors:
Additional Investors: HV Capital, Rheingau Founders, HarbourVest Partners, H14
Company Website: https://www.qualifyze.com/
Software Category: Compliance Solutions
About the Company: Qualifyze offers end-to-end compliance solutions for the pharmaceutical industry. It works on a global, digital network in which customers, suppliers, auditors, subcontractors, and authorities continuously and securely exchange quality data to make supply chains more transparent and secure. The company employs over 100 employees across offices in Frankfurt and Barcelona.
Source: https://tech.eu/2023/08/21/qualifyze-12m-thealthcare-supply-chain-compliance/